ArticleProstate cancer and prostatic diseases2021

Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate.

Rosario F Di Stefano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.